|
Our mission is to build a
leading Proteomics franchise, by advancing our core microfluidics
technology, and applying it to the discovery of novel protein targets, for
use in the development of new pharmaceuticals and improved markers for
disease management. The company has several protein targets already in
development.
The Proteomics revolution underway in Medical Research, the race to discover
all the proteins made by the cells in our bodies, will create enormous
value, as the protein targets discovered are patented, and become the basis
for the next generation of Pharmaceutical development. Protea Biosciences
believes that its Partnership with the WVU Health Sciences Center, and its
new technology in development, defines a strong position to participate
successfully in the emerging Proteomics sector, thereby building a
world-class proteomics company. |
|